This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring both ethyl and fluorine substituents, makes it valuable for creating molecules with specific biological activities, particularly in the development of drugs targeting central nervous system disorders and inflammatory conditions. Additionally, it serves as a building block in organic synthesis for the preparation of more complex chemical entities, often used in research and development to explore new therapeutic agents. Its fluorine component is particularly advantageous for enhancing the metabolic stability and bioavailability of drug candidates.